Increasing representation in the biomedical workforce would have many benefits, including reducing implicit biases and cultural incompetency in the treatment of minority patients with cancer, as well as ensuring the inclusion of diverse perspectives and enhancing innovation and creativity in cancer research.
Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and more news of the week from Cancer Today.
African American men are more likely to feel regret about prostate cancer treatment decisions, and more news of the week from Cancer Today.
People are using crowdsourced fundraising to cover cancer care costs, and more news of the week from Cancer Today.
Researchers in Japan observe the rare occurrence of a mother passing cancer cells to their child, and more news of the week from Cancer Today.
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex virus (HSV). He proposed that another virus—the human papillomavirus (HPV)—could lead to cervical cancer. While his initial studies...
As the year draws to a close, we bring you the final edition of Editors’ Picks for 2020. This monthly roundup features one “must read” article, handpicked by the editors, from each journal issue published by the AACR. Studies highlighted in this post include a review article...
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
Using deep learning to detect tumor mutations.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now